STOCK TITAN

Petros Pharmaceuticals to Participate in Two October 2022 Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Petros Pharmaceuticals (NASDAQ:PTPI) announces that President Fady Boctor will participate in two significant conferences in October 2022. The first event is the LD Micro Main Event XV in Los Angeles on October 25, where he will present at 4:30 pm PT and be available for one-on-one meetings. The second event is the 23rd Annual Fall Scientific Meeting of SMSNA in Miami from October 27 to 30, where he will represent the company at Booth 102. Petros focuses on developing innovative therapeutics for various men's health issues.

Positive
  • None.
Negative
  • None.

NEW YORK, NY / ACCESSWIRE / October 21, 2022 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will participate in two October 2022 conferences.

LD Micro Main Event XV (Los Angeles, CA)
Presentation Date: Tuesday, October 25
Time: 4:30 pm PT (Track 4)

The conference is being held on October 25 - 27, 2022 at the Luxe Sunset Boulevard Hotel in Los Angeles. Register to watch the presentation here. Mr. Boctor will be available for one-on-one meetings throughout the conference.

23rd Annual Fall Scientific Meeting of SMSNA (Miami, FL)
Participation Dates: Thursday, October 27 - Sunday, October 30
Time: 9:00 am - 6:00 pm ET (Booth: 102)

The SMSNA is considered the premier society in North America dedicated to progress and education in sexual medicine. The conference is being held at the Loews Miami Beach Hotel. For more information visit: https://issmsmsna2022.org/

About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health, and substance use disorders.

# # #

CONTACT:
Jules Abraham
CORE IR
917-885-7378
pr@coreir.com

SOURCE: Petros Pharmaceuticals, Inc.



View source version on accesswire.com:
https://www.accesswire.com/721533/Petros-Pharmaceuticals-to-Participate-in-Two-October-2022-Conferences

FAQ

What conferences will Petros Pharmaceuticals participate in October 2022?

Petros Pharmaceuticals will participate in the LD Micro Main Event XV in Los Angeles from October 25 to 27 and the 23rd Annual Fall Scientific Meeting of SMSNA in Miami from October 27 to 30.

Who from Petros Pharmaceuticals will speak at the conferences?

Fady Boctor, President and Chief Commercial Officer of Petros Pharmaceuticals, will speak at the conferences.

When is the LD Micro Main Event XV presentation by Petros Pharmaceuticals?

The LD Micro Main Event XV presentation will take place on October 25, 2022, at 4:30 pm PT.

What is the focus of Petros Pharmaceuticals?

Petros Pharmaceuticals focuses on developing therapeutics for men's health issues, including erectile dysfunction and Peyronie's disease.

Where will the 23rd Annual Fall Scientific Meeting of SMSNA be held?

The 23rd Annual Fall Scientific Meeting of SMSNA will be held at the Loews Miami Beach Hotel from October 27 to 30, 2022.

Petros Pharmaceuticals, Inc.

NASDAQ:PTPI

PTPI Rankings

PTPI Latest News

PTPI Stock Data

2.70M
9.20M
8.1%
2.29%
1.99%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
NEW YORK